FULLER H B CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FULLER H B CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Nov 30, 2019 | $739.11M | Jan 24, 2020 |
| FY2019 | Aug 31, 2019 | $725.38M | Jan 24, 2020 |
| FY2019 | Jun 1, 2019 | $759.58M | Jan 24, 2020 |
| FY2019 | Mar 2, 2019 | $672.94M | Jan 24, 2020 |
| FY2019 | Dec 1, 2018 | $768.43M | Jan 24, 2020 |
| FY2019 | Sep 1, 2018 | $770.11M | Jan 24, 2020 |
| FY2019 | Jun 2, 2018 | $789.39M | Jan 24, 2020 |
| FY2019 | Mar 3, 2018 | $713.08M | Jan 24, 2020 |
| FY2018 | Dec 2, 2017 | $678.20M | Jan 28, 2019 |
| FY2018 | Sep 2, 2017 | $562.87M | Jan 28, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $1.08B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $1.06B | Jan 22, 2026 |
| FY2025 | Dec 2, 2023 | $1.01B | Jan 22, 2026 |
| FY2024 | Dec 3, 2022 | $963.70M | Jan 23, 2025 |
| FY2023 | Nov 27, 2021 | $845.32M | Jan 24, 2024 |
| FY2020 | Nov 28, 2020 | $213.64M | Jun 29, 2021 |
| FY2020 | Aug 29, 2020 | $187.84M | Jun 29, 2021 |
| FY2020 | May 30, 2020 | $184.90M | Jun 29, 2021 |
| FY2020 | Feb 29, 2020 | $170.26M | Jun 29, 2021 |
| FY2020 | Nov 30, 2019 | $201.22M | Jun 29, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $151.97M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $130.26M | Jan 22, 2026 |
| FY2025 | Nov 29, 2024 | $130.26M | Jan 22, 2026 |
| FY2025 | Dec 2, 2023 | $144.91M | Jan 22, 2026 |
| FY2024 | Dec 3, 2022 | $180.31M | Jan 23, 2025 |
| FY2023 | Nov 27, 2021 | $161.39M | Jan 24, 2024 |
| FY2020 | Nov 28, 2020 | $40.60M | Jun 29, 2021 |
| FY2020 | Aug 29, 2020 | $41.61M | Jun 29, 2021 |
| FY2020 | May 30, 2020 | $31.61M | Jun 29, 2021 |
| FY2020 | Feb 29, 2020 | $9.90M | Jun 29, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Nov 30, 2024 | $348.22M | Jan 23, 2025 |
| FY2024 | Dec 2, 2023 | $355.14M | Jan 23, 2025 |
| FY2024 | Dec 3, 2022 | $322.72M | Jan 23, 2025 |
| FY2023 | Nov 27, 2021 | $252.61M | Jan 24, 2024 |
| FY2022 | Nov 28, 2020 | $218.32M | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $225.99M | Jan 25, 2022 |
| FY2020 | Dec 1, 2018 | $237.89M | Jun 29, 2021 |
| FY2019 | Dec 2, 2017 | $119.53M | Jan 24, 2020 |
| FY2018 | Dec 3, 2016 | $198.18M | Jan 28, 2019 |
| FY2017 | Nov 28, 2015 | $170.49M | Jan 31, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Nov 29, 2014 | $21.25M | Jan 28, 2015 |
| FY2013 | Nov 30, 2013 | $24.57M | Jan 24, 2014 |
| FY2012 | Dec 1, 2012 | $21.25M | Jan 29, 2013 |
| FY2011 | Dec 3, 2011 | $20.95M | Jan 27, 2012 |
| FY2011 | Nov 27, 2010 | $19.29M | Jan 27, 2012 |
| FY2011 | Nov 28, 2009 | $16.99M | Jan 27, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $725.59M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $713.66M | Jan 22, 2026 |
| FY2025 | Dec 2, 2023 | $653.76M | Jan 22, 2026 |
| FY2024 | Dec 3, 2022 | $640.98M | Jan 23, 2025 |
| FY2023 | Nov 27, 2021 | $592.71M | Jan 24, 2024 |
| FY2020 | Nov 28, 2020 | $139.71M | Jun 29, 2021 |
| FY2020 | Aug 29, 2020 | $129.11M | Jun 29, 2021 |
| FY2020 | May 30, 2020 | $128.00M | Jun 29, 2021 |
| FY2020 | Feb 29, 2020 | $141.51M | Jun 29, 2021 |
| FY2020 | Nov 30, 2019 | $148.52M | Jun 29, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $263.49M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $302.44M | Jan 22, 2026 |
| FY2025 | Dec 2, 2023 | $378.40M | Jan 22, 2026 |
| FY2024 | Dec 3, 2022 | $256.51M | Jan 23, 2025 |
| FY2023 | Nov 27, 2021 | $213.32M | Jan 24, 2024 |
| FY2022 | Nov 28, 2020 | $331.56M | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $269.18M | Jan 25, 2022 |
| FY2020 | Dec 1, 2018 | $253.31M | Jun 29, 2021 |
| FY2019 | Dec 2, 2017 | $166.33M | Jan 24, 2020 |
| FY2018 | Dec 3, 2016 | $195.69M | Jan 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $142.28M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $139.24M | Jan 22, 2026 |
| FY2025 | Dec 2, 2023 | $119.14M | Jan 22, 2026 |
| FY2024 | Dec 3, 2022 | $129.96M | Jan 23, 2025 |
| FY2023 | Nov 27, 2021 | $96.09M | Jan 24, 2024 |
| FY2022 | Nov 28, 2020 | $87.29M | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $61.98M | Jan 25, 2022 |
| FY2020 | Dec 1, 2018 | $68.26M | Jun 29, 2021 |
| FY2019 | Dec 2, 2017 | $54.93M | Jan 24, 2020 |
| FY2018 | Dec 3, 2016 | $63.31M | Jan 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $5.18B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $4.93B | Jan 22, 2026 |
| FY2024 | Dec 2, 2023 | $4.72B | Jan 23, 2025 |
| FY2022 | Dec 31, 2022 | $4.46B | Jan 24, 2023 |
| FY2023 | Dec 3, 2022 | $4.46B | Jan 24, 2024 |
| FY2022 | Dec 31, 2021 | $4.27B | Jan 24, 2023 |
| FY2022 | Nov 27, 2021 | $4.27B | Jan 24, 2023 |
| FY2021 | Nov 28, 2020 | $4.04B | Jan 25, 2022 |
| FY2020 | Nov 30, 2019 | $3.99B | Jun 29, 2021 |
| FY2019 | Dec 1, 2018 | $4.18B | Jan 24, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $3.18B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $3.10B | Jan 22, 2026 |
| FY2024 | Dec 2, 2023 | $2.97B | Jan 23, 2025 |
| FY2022 | Dec 31, 2022 | $2.85B | Jan 24, 2023 |
| FY2023 | Dec 3, 2022 | $2.85B | Jan 24, 2024 |
| FY2022 | Dec 31, 2021 | $2.68B | Jan 24, 2023 |
| FY2021 | Nov 27, 2021 | $2.68B | Jan 25, 2022 |
| FY2021 | Nov 28, 2020 | $2.65B | Jan 25, 2022 |
| FY2020 | Nov 30, 2019 | $2.76B | Jun 29, 2021 |
| FY2019 | Dec 1, 2018 | $3.02B | Jan 24, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $2.00B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $1.83B | Jan 22, 2026 |
| FY2024 | Dec 2, 2023 | $1.76B | Jan 23, 2025 |
| FY2022 | Dec 31, 2022 | $1.61B | Jan 24, 2023 |
| FY2023 | Dec 3, 2022 | $1.61B | Jan 24, 2024 |
| FY2022 | Dec 31, 2021 | $1.60B | Jan 24, 2023 |
| FY2021 | Nov 27, 2021 | $1.60B | Jan 25, 2022 |
| FY2021 | Nov 28, 2020 | $1.38B | Jan 25, 2022 |
| FY2020 | Nov 30, 2019 | $1.22B | Jun 29, 2021 |
| FY2019 | Dec 1, 2018 | $1.15B | Jan 24, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $1.68B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $1.53B | Jan 22, 2026 |
| FY2024 | Dec 2, 2023 | $1.49B | Jan 23, 2025 |
| FY2022 | Dec 31, 2022 | $1.39B | Jan 24, 2023 |
| FY2023 | Dec 3, 2022 | $1.39B | Jan 24, 2024 |
| FY2022 | Dec 31, 2021 | $1.30B | Jan 24, 2023 |
| FY2022 | Nov 27, 2021 | $1.30B | Jan 24, 2023 |
| FY2021 | Nov 28, 2020 | $1.31B | Jan 25, 2022 |
| FY2021 | Nov 30, 2019 | $1.28B | Jan 25, 2022 |
| FY2020 | Dec 1, 2018 | $1.31B | Jun 29, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $2.03B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $1.92B | Jan 22, 2026 |
| FY2024 | Dec 2, 2023 | $1.84B | Jan 23, 2025 |
| FY2022 | Dec 31, 2022 | $1.74B | Jan 24, 2023 |
| FY2023 | Dec 3, 2022 | $1.74B | Jan 24, 2024 |
| FY2022 | Dec 31, 2021 | $1.60B | Jan 24, 2023 |
| FY2021 | Nov 27, 2021 | $1.60B | Jan 25, 2022 |
| FY2021 | Nov 28, 2020 | $1.47B | Jan 25, 2022 |
| FY2020 | Nov 30, 2019 | $1.38B | Jun 29, 2021 |
| FY2019 | Dec 1, 2018 | $1.29B | Jan 24, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $107.21M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $169.35M | Jan 22, 2026 |
| FY2024 | Dec 2, 2023 | $179.45M | Jan 23, 2025 |
| FY2022 | Dec 31, 2022 | $79.91M | Jan 24, 2023 |
| FY2023 | Dec 3, 2022 | $79.91M | Jan 24, 2024 |
| FY2022 | Dec 31, 2021 | $61.79M | Jan 24, 2023 |
| FY2021 | Nov 27, 2021 | $61.79M | Jan 25, 2022 |
| FY2021 | Nov 28, 2020 | $100.53M | Jan 25, 2022 |
| FY2020 | Nov 30, 2019 | $112.19M | Jun 29, 2021 |
| FY2019 | Dec 1, 2018 | $150.79M | Jan 24, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $2.02B | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $2.01B | Jan 22, 2026 |
| FY2024 | Dec 2, 2023 | $1.84B | Jan 23, 2025 |
| FY2023 | Dec 3, 2022 | $1.74B | Jan 24, 2024 |
| FY2022 | Nov 27, 2021 | $1.59B | Jan 24, 2023 |
| FY2021 | Nov 28, 2020 | $1.76B | Jan 25, 2022 |
| FY2020 | Nov 30, 2019 | $1.96B | Jun 29, 2021 |
| FY2019 | Dec 1, 2018 | $2.23B | Jan 24, 2020 |
| FY2018 | Dec 2, 2017 | $2.42B | Jan 28, 2019 |
| FY2017 | Dec 3, 2016 | $665.94M | Jan 31, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | 2 | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | 2 | Jan 22, 2026 |
| FY2025 | Dec 2, 2023 | 2 | Jan 22, 2026 |
| FY2024 | Dec 3, 2022 | 3 | Jan 23, 2025 |
| FY2023 | Nov 27, 2021 | 3 | Jan 24, 2024 |
| FY2020 | Nov 28, 2020 | 0 | Jun 29, 2021 |
| FY2020 | Aug 29, 2020 | 0 | Jun 29, 2021 |
| FY2020 | May 30, 2020 | 0 | Jun 29, 2021 |
| FY2020 | Feb 29, 2020 | 0 | Jun 29, 2021 |
| FY2020 | Nov 30, 2019 | 0 | Jun 29, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | 2 | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | 2 | Jan 22, 2026 |
| FY2025 | Dec 2, 2023 | 2 | Jan 22, 2026 |
| FY2024 | Dec 3, 2022 | 3 | Jan 23, 2025 |
| FY2023 | Nov 27, 2021 | 2 | Jan 24, 2024 |
| FY2020 | Nov 28, 2020 | 0 | Jun 29, 2021 |
| FY2020 | Aug 29, 2020 | 0 | Jun 29, 2021 |
| FY2020 | May 30, 2020 | 0 | Jun 29, 2021 |
| FY2020 | Feb 29, 2020 | 0 | Jun 29, 2021 |
| FY2020 | Nov 30, 2019 | 0 | Jun 29, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | 54.17M | Jan 22, 2026 |
| FY2025 | Dec 2, 2024 | 54.09M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | 54.66M | Jan 22, 2026 |
| FY2025 | Dec 3, 2023 | 53.68M | Jan 22, 2026 |
| FY2025 | Dec 2, 2023 | 54.09M | Jan 22, 2026 |
| FY2022 | Dec 31, 2022 | 53.68M | Jan 24, 2023 |
| FY2024 | Dec 3, 2022 | 53.68M | Jan 23, 2025 |
| FY2022 | Dec 31, 2021 | 52.78M | Jan 24, 2023 |
| FY2024 | Nov 27, 2021 | 52.78M | Jan 23, 2025 |
| FY2023 | Nov 28, 2020 | 51.91M | Jan 24, 2024 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 29, 2025 | $50.27M | Jan 22, 2026 |
| FY2025 | Nov 30, 2024 | $47.60M | Jan 22, 2026 |
| FY2025 | Dec 2, 2023 | $43.40M | Jan 22, 2026 |
| FY2024 | Dec 3, 2022 | $39.21M | Jan 23, 2025 |
| FY2023 | Nov 27, 2021 | $34.86M | Jan 24, 2024 |
| FY2022 | Nov 28, 2020 | $33.46M | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $32.36M | Jan 25, 2022 |
| FY2020 | Dec 1, 2018 | $31.12M | Jun 29, 2021 |
| FY2019 | Dec 2, 2017 | $29.61M | Jan 24, 2020 |
| FY2018 | Dec 3, 2016 | $27.52M | Jan 28, 2019 |